Skip to main content
Equibles

Squarepoint Ops LLC

Position in BSX — Boston Scientific Corp

CIK 1642575 NEW YORK, NY
Back to BSX Full portfolio

Position in BSX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$99,767,103
-$189,647,607 QoQ
Shares Held
1,589,914
-47.6% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Mar 31, 2026
CallValue
$16,773,075
CallShares
267,300
PutValue
$11,414,225
PutShares
181,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $569,835,394 across 47 Medical Devices names. BSX ranks #2 (17.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MDT
Medtronic plc
 1,683,504 $145,875,621
2 BSX
Boston Scientific Corp
This page 		1,589,914 $99,767,103
3 DXCM
Dexcom Inc
 1,154,441 $72,498,894
4 MASI
Masimo Corp
 389,359 $69,255,285
5 PEN
Penumbra Inc
 147,806 $48,535,056
6 ABT
Abbott Laboratories
 397,572 $40,818,717
7 SYK
Stryker Corp
 109,964 $36,133,070
8 GKOS
GLAUKOS Corp
 108,049 $11,632,555

All Filings in BSX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $99,767,103 1,589,914
2026-03-31 $16,773,075 267,300
2026-03-31 $11,414,225 181,900
2025-12-31 $5,129,830 53,800
2025-12-31 $6,970,085 73,100
2025-12-31 $289,414,710 3,035,288
2025-09-30 $10,046,127 102,900
2025-09-30 $5,174,390 53,000
2025-09-30 $179,166,768 1,835,161
2025-06-30 $23,871,335 222,245
2025-06-30 $51,771,620 482,000
2025-06-30 $58,162,515 541,500
2025-03-31 $22,476,568 222,805
2025-03-31 $20,024,680 198,500
2025-03-31 $18,097,872 179,400
2024-12-31 $15,166,536 169,800
2024-12-31 $23,482,228 262,900
2024-12-31 $14,546,208 162,855
2024-09-30 $29,558,271 352,724
2024-09-30 $13,491,800 161,000
2024-09-30 $5,296,160 63,200
2024-06-30 $8,345,111 108,364
2024-06-30 $6,722,973 87,300
2024-06-30 $7,423,764 96,400
2024-03-31 $3,078,214 44,944
2024-03-31 $4,992,921 72,900
2024-03-31 $14,239,071 207,900
2023-12-31 $2,445,363 42,300
2023-12-31 $8,128,086 140,600
2023-12-31 $3,373,560 58,356
2023-09-30 $6,209,280 117,600
2023-09-30 $813,120 15,400
2023-09-30 $6,608,025 125,152
2023-06-30 $1,801,197 33,300
2023-06-30 $3,851,208 71,200
2023-06-30 $42,952,165 794,087
2023-03-31 $8,803,328 175,961
2022-12-31 $527,478 11,400
2022-12-31 $2,605,001 56,300
2022-12-31 $8,755,579 189,228
2022-09-30 $2,180,499 56,300
2022-09-30 $441,522 11,400
2022-06-30 $8,698,967 233,404
2022-06-30 $1,446,076 38,800
2022-06-30 $5,620,316 150,800
2022-03-31 $10,408,150 235,000
2022-03-31 $14,513,257 327,687
2022-03-31 $1,957,618 44,200
2021-12-31 $3,300,696 77,700
2021-12-31 $8,865,576 208,700

Report a Problem

Category
Description
Email (optional, for follow-up)